Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Forest Laboratories (FRX)

Add to Watchlists
Create an Alert
91.67 -0.46  -0.50% NYSE Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
FRX Price Chart
View All Events

FRX Events

Date Type Description
Apr 29 Misc Q4 2013 Forest Laboratories, Inc. Earnings Conference Call
Apr 29 Earnings Q4 2013 Forest Laboratories, Inc. Earnings Results. Estimate: 0.44.
Jan 21 Misc FY14 Q3 Forest Laboratories, Inc. Earnings Conference Call
Jan 21 Earnings FY14 Q3 Forest Laboratories, Inc. Earnings Result. Estimate: 0.06.
Dec 02 Misc Forest Laboratories, Inc. Investor Call
Oct 22 Misc Q2 2014 Earnings Conference Call
Oct 22 Earnings Q2 2014 Earnings Release. Estimate: 0.13.
Aug 15 Misc AGM Event for Forest Laboratories, Inc.
Jul 23 Misc Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 First Quarter Earnings
Jul 23 Earnings Fiscal 2014 First Quarter Earnings Results. Estimate: 0.07.
View All Performance Charts

FRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Forest Laboratories is up 153.7% over the last year vs S&P 500 Total Return up 22.59%, Ironwood Pharmaceuticals down 34.07%, and Actavis up 108.0%.

Get Quote for

PDF Report for FRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download FRX Pro Report PDF

Portfolio Strategies Featuring FRX

Did Forest Laboratories make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

FRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: March 31, 2015
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Forest Laboratories, Inc. is a US based pharmaceutical company, engaged in identifying, developing, manufacturing and marketing of pharmaceutical products including ethical and over the counter drugs in branded and generic forms. Forest has franchises in the areas of cardiovascular and central nervous systems. The company is present in therapeutic areas including cardiovascular, central nervous system, endocrinology, pain management, and respiratory. As of 2007, approached almost a billion US dollars a year, which put it on the list of the top 100 global corporations in R&D spending. Forest Laboratories is also known for licensing European pharmaceuticals for sale in the United States. The company operates in the US, Ireland, Netherlands and the UK through its subsidiaries. Forest Laboratories is headquartered in New York, the US.

Recent Quotes

Symbol Price Chg Chg % Market Cap
FRX 91.67 -0.46 -0.50% 24.75B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.